• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Med Sci . Risk factors for illness severity in patients with COVID-19 pneumonia: a prospective cohort study

tetano

Editor, Senior Moderator
Int J Med Sci


. 2021 Jan 1;18(4):921-928.
doi: 10.7150/ijms.51205. eCollection 2021.
Risk factors for illness severity in patients with COVID-19 pneumonia: a prospective cohort study


Nannan Zhang[SUP] 1 [/SUP], Hairong Zhang[SUP] 2 [/SUP], Yanhua Tang[SUP] 1 [/SUP], Hao Zhang[SUP] 3 [/SUP], Aiying Ma[SUP] 4 [/SUP], Fang Xu[SUP] 1 [/SUP], Yu Sun[SUP] 5 [/SUP], Luning Jiang[SUP] 1 [/SUP], Fangzhen Shan[SUP] 6 7 [/SUP]



Affiliations

Abstract

Background: Although COVID-19 pneumonia is spreading internationally, knowledge regarding the factors associated with the illness severity of patients remains limited. We aimed to identify the factors associated with the disease severity of patients with COVID-19 pneumonia induced by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Methods: We prospectively enrolled a single-center case series of adult patients with COVID-19 admitted to the Infectious Disease Hospital of Jining, Jining City, Shandong Province, China, from January 24 to March 1, 2020. Demographics, clinical characteristics, and laboratory findings were compared to investigate the risk factors related with the disease severity of COVID-19 pneumonia patients. Results: We included a total of 78 patients with COVID-19 pneumonia, of whom 6 had the severe type. As compared to a moderately ill cohort, our analysis showed that shortness of breath, fatigue, longer days from illness onset to diagnosis confirmed, neutrophil percentages > 70%, neutrophil counts > 6.3 ? 10[SUP]9[/SUP]/L, lymphocyte percentages < 20%, lymphocyte counts < 1.0 ? 10[SUP]9[/SUP]/L, platelet < 100 ? 10[SUP]9[/SUP]/L, C-reactive protein (CRP) > 10 mg/L, neutrophil to platelet ratio (NPR) > 2.3, neutrophil to lymphocyte ratio (NLR) > 3.9, aspartate aminotransferase (AST) > 40 U/L, albumin < 40 g/L, lactate dehydrogenase (LDH) > 245 U/L, and glucose > 6.1 mmol/L were predictors of disease severity in COVID-19 pneumonia. In the sex-, age-, and comorbid illness-matched case-control study, neutrophil percentages > 70%, neutrophil counts > 6.3 ? 10[SUP]9[/SUP]/L, lymphocyte percentages < 20%, NPR > 2.3, NLR > 3.9, albumin < 40 g/L, and LDH > 245 U/L remained associated with the early detection and identification of severe patients. Conclusion: We demonstrated that neutrophil percentages > 70%, neutrophil counts > 6.3 ? 10[SUP]9[/SUP]/L, lymphocyte percentages < 20%, NPR > 2.3, NLR > 3.9, albumin < 40 g/L, and LDH > 245 U/L might predict the severity of illness in patients with COVID-19 pneumonia.

Keywords: COVID-19; SARS-CoV-2; prospective studies; risk factor; severity.
 
Back
Top Bottom